Recruiting

TSS

Sponsor:

University of Mississippi Medical Center

Code:

NCT05457205

Conditions

Spinal Cord Injuries

Spasticity, Muscle

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Electrical neuromodulation

Study Details

Brief summary:

Spasticity develops months after spinal cord injury (SCI) and persists over time. It presents as a mixture of tonic features, namely increased muscle tone (hypertonia) and phasic features, such as hyperactive reflexes (hyperreflexia), clonus, and involuntary muscle contractions (spasms). Spasticity is often disabling because it interferes with hygiene, transfers, and locomotion and can disturb sleep and cause pain. For these reasons, most individuals seek treatments for spasticity after SCI. New developments in electrical neuromodulation with transcutaneous spinal stimulation (TSS) show promising results in managing spasticity non-pharmacologically. The underlying principle of TSS interventions is that the afferent input generated by posterior root stimulation modifies the excitability of the lumbosacral network to suppress pathophysiologic spinal motor output contributing to distinctive features of spasticity. However, the previous TSS studies used almost identical protocols in terms of stimulation frequency and intensity despite the great flexibility offered by this treatment strategy and the favorable results with the epidural stimulation at higher frequencies. Therefore, the proposed study takes a new direction to systematically investigate the standalone and comparative efficacy of four TSS interventions, including those used in previous studies.

Our central hypothesis is that electrical neuromodulation with the selected TSS protocols (frequency: 50/100 Hz; intensity: 0.45 or 0.9 times the sub-motor threshold) can reduce and distinctly modify tonic and phasic components of spasticity on short- and long-term basis. We will test our hypothesis using a prospective, experimental, cross-over, assessor-masked study design in 12 individuals with chronic SCI (more than 1-year post-injury).

Aim 1. Determine the time course of changes and immediate after-effects of each TSS protocol on tonic and phasic spasticity. The results will reveal the evolution of changes in spasticity during 30-min of TSS and the most effective protocol for producing immediate aftereffects.

Aim 2. Determine the effect of TSS on spasticity after a trial of home-based therapy with each protocol. The participants will administer 30 min of TSS daily for six days with each of the four TSS protocols selected randomly. This aim will reveal the long-term carry-over effects of TSS intervention on various components of spasticity after SCI.

Aim 3. Determine the participants' experience with TSS as a home-based therapy through focus group meetings. We will conduct focus group meetings after participants finish the home-based therapy trial. Accomplishing this specific aim will provide a valuable perspective on the value, challenges, and acceptability of TSS as a home-based intervention.

The study addresses important questions for advancing scientific knowledge and clinical management of spasticity after SCI. Specifically, it will examine the efficacy of TSS frequencies and intensities on tonic and phasic spasticity. The study results will be relevant for a high proportion of individuals living with SCI that could benefit from this novel and low-cost non-pharmacological approach to managing spasticity after SCI.

Conditions

Spinal Cord Injuries

Spasticity, Muscle

Study ID

NCT05457205

Start date

Aug 16, 2022

Status verified date

Apr, 2024

Completion date

Apr 5, 2025

Anticipated

Primary completion date

Feb 28, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 years or older
  • History of SCI (ASIA Impairment Scale grades A-D)
  • Time since injury longer than 6 months
  • The presence of at least mild spasticity (>3) in the lower limbs by self-report of the Numerical Rating Scale (from 0 to 10) of spasticity severity
  • Signed consent form

Exclusion Criteria:

  • Neurological level of SCI below T11
  • Suspected progression of SCI (e.g., syringomyelia)
  • Ventilatory-dependent
  • Implanted active devices (e.g., intrathecal baclofen pumps)
  • Passive implants (plates, screws) between T10 and L3 vertebras
  • Skin conditions precluding placement of electrodes
  • Ongoing infections
  • Pregnancy
  • Difficulty following instructions
  • No access to a caregiver/family member to help with electrode placement at home
  • Other medical risks/contraindications as determined by the study physicians

Study Design

Enrollment

12 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Neuromodulation with 50 Hz and low intensity

Transcutaneous spinal stimulation for 30 min with a stimulation frequency of 50 Hz and stimulation intensity of 0.45 x lowest motor threshold (reflex threshold in leg muscles).

experimental: Neuromodulation with 50 Hz and high intensity

Transcutaneous spinal stimulation for 30 min with a stimulation frequency of 50 Hz and stimulation intensity of 0.90 x lowest motor threshold (reflex threshold in leg muscles).

experimental: Neuromodulation with 100 Hz and low intensity

Transcutaneous spinal stimulation for 30 min with a stimulation frequency of 100 Hz and stimulation intensity of 0.45 x lowest motor threshold (reflex threshold in leg muscles).

experimental: Neuromodulation with 100 Hz and high intensity

Transcutaneous spinal stimulation for 30 min with a stimulation frequency of 100 Hz and stimulation intensity of 0.90 x lowest motor threshold (reflex threshold in leg muscles).

Interventions

Electrical neuromodulation

Electrical neuromodulation intervention using transcutaneous spinal stimulation: two self-adhesive semicircle electrodes (forming a 5cm round electrode) will be centered midline over the T11-12 spinal processes, and two 8×13 cm electrodes will be placed paraumbilical and interconnected to serve as a counter electrode. A current-controlled stimulator will deliver symmetric biphasic pulses (500-μs/phase). Electrical stimulation will be applied according to the description in each study arm.

Primary outcome measure

  • Change in posterior root reflex amplitude [ Time Frame: Before and after an intervention session (30 minutes) ]
  • Change in posterior root reflex amplitude (during intervention) [ Time Frame: Before and during an intervention session (15 minutes) ]
  • Change in flexion withdrawal reflex root-mean-square [ Time Frame: Before and after an intervention session (30 minutes) ]
  • Change in flexion withdrawal reflex root-mean-square (during intervention) [ Time Frame: Before and during an intervention session (15 minutes) ]
  • Change in pendulum test index [ Time Frame: Before and after an intervention session (30 minutes) ]
  • Change in pendulum test index (during intervention) [ Time Frame: Before and during an intervention session (15 minutes) ]

Central Contacts and Locations

Central contacts

Matthias J Krenn, PhD

601-364-3413mkrenn@umc.edu

Dobrivoje S Stokic, MD, DSc

601-364-3314dstokic@mmrcrehab.org

Locations

Methodist Rehabilitation Center

Recruiting

Jackson, Mississippi, United States, 39216

Contacts

Dobrivoje S Stokic, MD, DSc

601-364-3314dstokic@mmrcrehab.org

University of Mississippi Medical Center

Recruiting

Jackson, Mississippi, United States, 39216

Contacts

Matthias J Krenn, PhD

601-364-3413mkrenn@umc.edu

More Information

Sponsor

University of Mississippi Medical Center

Last update posted

Apr 12, 2024

Last verified

Apr, 2024

Keywords

  • Transcutaneous Spinal Cord Stimulation
  • Neuromodulation
  • Electrical Stimulation
  • Spasticity
  • Lower Extremities

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Mississippi Medical Center on 2024-04-12.